Initial motor symptoms of Parkinson disease

Neurologist

Volumn 17, Issue 6 SUPPL., 2011, Pages

  Ruiz, Pedro J Garcia ^a   Catalan M J ^b   Carril, J M Fernández ^c  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c Hospital de Guadalajara   (Spain)

Author keywords

bradykinesia; early motor symptoms; gait disturbances; Parkinson disease; rigidity; tremor

Indexed keywords

BOTULINUM TOXIN A; LEVODOPA;

AGILITY; BODY EQUILIBRIUM; BRADYKINESIA; BULBAR PARALYSIS; CLINICAL PRACTICE; CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; DYSARTHRIA; DYSPHAGIA; DYSTONIA; GAIT DISORDER; HUMAN; HYPERSALIVATION; LEG; MOTOR PERFORMANCE; MUSCULOSKELETAL PAIN; PARKINSON DISEASE; PHYSICAL EXAMINATION; POSTURAL REFLEX; PRIORITY JOURNAL; REFLEX; RIGIDITY; TREMOR; WALKING;

DYSTONIA; HUMANS; HYPOKINESIA; PARKINSON DISEASE; TREMOR;

EID: 80455131112     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e31823966b4     Document Type: Conference Paper

References (35)

1. Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet. 2009;373:2055-2066.
2. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: Diagnosis and management. Lancet Neurol. 2006;5:235-245.
3. Truong DD, Bhidayasiri R, Wolters E. Management of non-motor symptoms in advanced Parkinson disease. J Neurol Sci. 2008;266: 216-228.
4. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatr. 1992;55:181-184.
5. Berardelli A, Rothwell JC, Thompson PD, et al. Pathophysiology of bradykinesia in Parkinson's disease. Brain. 2001;124:2131-2146.
6. Martinez Martin P, Gil-Nagel A, Morlan Gracia L, et al. Unified Parkinson's disease Rating Scale, characteristics and structure. Mov Disord. 1994;9:76-83.
7. Garcia Ruiz PJ, Muñiz de Igneson J, Ayerbe J, et al. Evaluation of timed tests in advanced Parkinsonian patients who were candidates for subthalamic stimulation. Clin Neuropharmacol. 2005;28:15-17.
8. Salarian A, Zampieri C, Horak FB, et al. Analyzing 180 degrees turns using an inertial system reveals early signs of progression of Parkinson's disease. Conf Proc IEEE Eng Med Biol Soc. 2009; 224-227.
9. Vaugoyeau M, Viallet F, Mesure S, et al. Coordination of axial rotation and step execution: Deficits in Parkinson's disease. Gait Posture. 2003;18:150-157.
10. Vaugoyeau M, Viallet F, Aurenty R, et al. Axial rotation in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006; 77:815-821.
11. Gunzler SA, Pavel M, Koudelka C, et al. Foot-tapping rate as an objective outcome measure for Parkinson disease clinical trials. Clin Neuropharmacol. 2009;32:97-102.
12. Clissold BG, McColl CD, Reardon KR, et al. Longitudinal study of the motor response to levodopa in Parkinson's disease. Mov Disord. 2006;21:2116-2121.
13. Wilson KSA. Paralysis Agitans. In: Bruce N, ed. Neurology by Kinnier Wilson. Vol II: London: Edward Arnold & Co; 1940: 787-805.
14. Maetzler W, Liepilt I, Berg D. Progression of Parkinson's disease in the clinical phase: Potential markers. Lancet Neurol. 2009;8: 1158-1171.
15. Gironell A, Kulisevsky J, Pascual-Sedano B, et al. Prodromic tremor: Prevalence and clinical correlates. Mov Disord. 2007; 22:1203-1204.
16. de Lau LM, Koudstaal PJ, Hofman A, et al. Subjective complaints precede Parkinson disease: The Rotterdam study. Arch Neurol. 2006;63:362-365.
17. Ferguson LW, Rajput ML, Muhajarine N, et al. Clinical features at first visit and rapid disease progression in Parkinson's disease. Parkinsonism Relat Disord. 2008;14:431-435.
18. Kwon PS, Verghese J. Walking while talking: A dopamineresponsive task in early Parkinson's disease. J Am Geriatr Soc. 2005;53:735-737.
19. Morris M, Huxham F, McGinley JI. Gait disorders and gait rehabilitation in Parkinson disease. Adv Neurol. 2001;87:347-361.
20. Parkinson J. An Essay on the Shaking Palsy. London: Sherwood, Neely and Jones; 1817.
21. Gowers WR. Paralysis agitans. A Manual of Diseases of the Nervous System.Vol II: Philadelphia: Blakiston, Son & Co; 1893:637-657.
22. Buzzard TA. Clinical lecture on shaking palsy. Brain. 1882;4:473-492.
23. Giladi N. Freezing of gait: clinical overview. Adv Neurol. 2001;87:191-197.
24. Ambani LM, Van Woert MH. Start hesitation, a side effect of long-term levodopa therapy. N Engl J Med. 1973;288:1113-1115.
25. Bartels AL, Balash Y, Gurevich T, et al. Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia. J Clin Neurosci. 2003;10:584-588.
26. Nutt JG, Bloem BR, Giladi N, et al. Freezing of gait: Moving forward on a mysterious clinical phenomenon. Lancet Neurol. 2011;10:734-744.
27. Wright WG, Gurfinkel VS, Nutt J, et al. Axial hypertonicity in Parkinson's disease: Direct measurements of trunk and hip torque. Exp Neurol. 2007;208:38-46.
28. Franzén E, Paquette C, Gurfinkel VS, et al. Reduced performance in balance, walking and turning tasks is associated with increased neck tone in Parkinson's disease. Exp Neurol. 2009; 219:430-438.
29. Shahed J, Jankovic J. Motor symptoms in Parkinsonś disease. Handbook Clin Neurol. 2007;83:329-342.
30. Schrag A, Schott JM. Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurol. 2006; 5:355-363.
31. Khan NL, Graham E, Critchley P, et al. Parkin disease: A phenotypic study of a large case series. Brain. 2003;126: 1279-1292.
32. Bozi M, Bhatia KP. Paroxysmal exercise-induced dystonia as a presenting feature of young-onset Parkinson's disease. Mov Disord. 2003;18:1545-1547.
33. Pfeiffer R. Multiple system atrophy. Handbook Clin Neurol. 2007; 83:307-326.
34. Burn D, Lees A. Progressive supranuclear palsy. Handbook Clin Neurol. 2007;83:327-350.
35. Guidubaldi A, Fasano A, Ialongo T, et al. Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. Mov Disord. 2011;26:313-319.